Mescaline (Phenethylamine Psychedelic · 5-HT2A Agonist · Peyote · Informational Reference)

Compound	Mescaline (3,4,5-Trimethoxyphenethylamine)
Chemical class	Alkaloid — Protoalkaloid / Phenethylamine (Trimethoxyphenethylamine; psychedelic)
CAS	54-04-6
Primary source	Lophophora williamsii (peyote cactus buttons), Trichocereus pachanoi (San Pedro cactus), Echinopsis peruviana (Peruvian torch)
Key applications	Controlled psychedelic; serotonin 5-HT2A/2C agonism; traditional Native American ceremonial use; research; informational reference
Claim strength	Moderate (5-HT2A agonism pharmacology); Informational only
Typical form	Controlled substance (Schedule I US, UK; Annex I EU); not a supplement or pharmaceutical ingredient
Buy from Herbuno	Browse HerbIQ Compound Index →

Name origin: From Mescalero Apache (a Native American people for whom peyote was ceremonially important) — or from mescal (a Spanish corruption of the Nahuatl mexcalli). Mescaline was isolated from peyote by Arthur Heffter in 1897 (in a notable act of self-experimentation) and synthesised by Ernst Spath in 1919. It is the primary psychoactive alkaloid of peyote (Lophophora williamsii) and also occurs in several columnar cacti (Trichocereus species). Traditional use: Peyote has been used ceremonially by Native American peoples in Mexico and the US Southwest for at least 5,700 years (confirmed by radiocarbon-dated archaeological evidence from a Texas rockshelter). The Native American Church uses peyote as a sacrament in religious ceremonies — a use granted a federal exemption from the Controlled Substances Act (American Indian Religious Freedom Act amendments, 1994). Peyote is one of the oldest documented ritual psychedelic plants in human culture. Pharmacology: Mescaline is a full agonist at 5-HT2A and 5-HT2C receptors — the same receptors activated by psilocybin, LSD, and DMT. The 5-HT2A agonism in the prefrontal cortex produces the characteristic psychedelic phenomenology: visual hallucinations, altered time perception, ego dissolution, mystical experience. Mescaline also has mild dopaminergic and alpha-adrenergic activity. Duration of effect is 8–12 hours (significantly longer than psilocybin’s 4–6 hours). Regulatory status: Schedule I (US), Class A (UK), Schedule I (EU directive). The Native American Church peyote exemption applies only to enrolled tribal members. Not available as a dietary supplement in any jurisdiction.

---

Mescaline — Pharmacological and Cultural Context

5-HT2A receptor agonism — psychedelic mechanism: Mescaline’s psychedelic effects are primarily mediated by 5-HT2A agonism in pyramidal neurons of layer V in the prefrontal cortex, disrupting the normal filtering of sensory information and producing the hallucinatory experience. The molecular pharmacology of mescaline at 5-HT2A is similar to psilocybin and LSD — making it part of the classic serotonergic psychedelic class that is currently under intense clinical investigation for depression, PTSD, and addiction treatment. Mescaline itself has fewer modern clinical studies than psilocybin and LSD. Pharmacological reference.

Historical research and clinical context: Mescaline was the first psychedelic to be subjected to systematic scientific investigation — Havelock Ellis (1897), Aldous Huxley (The Doors of Perception, 1954), and Henri Michaux wrote influential accounts of its phenomenology. German psychiatrist Kurt Beringer’s Der Meskalinrausch (1927) was the first systematic psychiatric study of a psychedelic. These early investigations established the framework for understanding psychedelic phenomenology that continues to inform contemporary clinical research. Historical reference.

Microdosing research context: Unlike psilocybin and LSD, mescaline has not been incorporated into the current wave of clinical psychedelic research — largely because peyote’s cultural and protected status, and the availability of the synthetic forms, have kept mescaline outside the mainstream clinical trial framework. Some researchers advocate for mescaline inclusion in psychedelic research given its distinct phenomenological profile (longer duration, reportedly more body-centred and less anxiety-provoking than LSD). Research reference.

---

Frequently Asked Questions — Mescaline

How does mescaline differ from psilocybin and LSD?
All three are serotonergic psychedelics acting primarily via 5-HT2A agonism. Differences: mescaline is a phenethylamine (not an indole/tryptamine or ergoline); its duration is 8–12 hours (psilocybin 4–6 hours, LSD 8–12 hours); mescaline is reportedly more “empathogenic” (phenethylamine structural kinship with MDMA) with more visual and body-centred effects; mescaline requires higher doses by weight (200–400 mg vs psilocybin’s 25 mg); mescaline has a longer onset (1–2 hours vs psilocybin 30–60 min). Aldous Huxley described mescaline as uniquely suited for exploring the aesthetic dimension of consciousness relative to LSD.

What is the therapeutic research status of mescaline?
Minimal compared to psilocybin and MDMA. No Phase II mescaline clinical trials are registered for psychiatric indications. The research focus has been on psilocybin (depression, addiction, end-of-life anxiety — multiple Phase IIb trials with promising results) and MDMA-assisted therapy for PTSD (Phase III completed; FDA approval application submitted). Mescaline’s longer duration, lower availability, and peyote cultural sensitivity have limited its inclusion in the clinical research pipeline.

Is San Pedro cactus (Trichocereus pachanoi) legal to grow?
In the US, peyote (Lophophora williamsii) is specifically listed as a Schedule I controlled substance. Trichocereus species (San Pedro, Peruvian torch) containing mescaline are in a complex legal grey zone: the plants themselves are often sold legally as ornamental cacti, but extracting or preparing mescaline from them is a federal controlled substance violation. The DEA has not specifically listed Trichocereus by plant name, but mescaline extracted from any source is Schedule I. This creates a legal ambiguity that varies by jurisdiction.

What makes peyote culturally significant to Native American peoples?
Peyote use in the Native American Church is not primarily recreational or therapeutic in the Western clinical sense — it is a sacramental practice integrating prayer, community, and spiritual healing within a specifically Native American Christian framework. The ceremony is led by a Road Chief (ceremony leader) and involves all-night prayer meetings with singing, peyote ingestion, and spiritual reflection. The US federal exemption for Native American Church peyote use recognises this as constitutionally protected religious practice, distinct from recreational or research psychedelic use.

Related compounds: Tryptamine, Harmine, Bufotenin, Synephrine

---

Claim-strength scale – High = multiple human RCTs; Moderate = limited trials or strong preclinical convergence; Emerging = early-stage lab or animal data.

← HerbIQ Compound Index · HerbIQ P02: Extraction · HerbIQ P03: Delivery